LENSKART SOLUTIONS
Back to Cashflow Statement
|
LENSKART SOLUTIONS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹1,201 Cr | ₹-535 Cr | ₹-722 Cr | ₹2,777 Cr | ₹604 Cr |
What is the latest Cash Flow from Financing Activities ratio of LENSKART SOLUTIONS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹1,201 Cr |
| Mar2025 | ₹-535 Cr |
| Mar2024 | ₹-722 Cr |
| Mar2023 | ₹2,777 Cr |
| Mar2022 | ₹604 Cr |
How is Cash Flow from Financing Activities of LENSKART SOLUTIONS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,201 Cr | Positive | |
| Mar2025 | ₹-535 Cr | Negative | |
| Mar2024 | ₹-722 Cr | Negative | |
| Mar2023 | ₹2,777 Cr | 359.57 | |
| Mar2022 | ₹604 Cr | - | |
Compare Cash Flow from Financing Activities of peers of LENSKART SOLUTIONS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LENSKART SOLUTIONS | ₹98,645.1 Cr | 1.4% | 5.9% | NA | Stock Analytics | |
| POLY MEDICURE | ₹17,469.3 Cr | 2.8% | 2.2% | -12.5% | Stock Analytics | |
| LAXMI DENTAL | ₹1,199.6 Cr | 0.3% | -3.2% | -49.9% | Stock Analytics | |
| 3B BLACKBIO DX | ₹1,060.5 Cr | -2.9% | 2.5% | -17.4% | Stock Analytics | |
| PREVEST DENPRO | ₹461.0 Cr | -1.3% | -3.3% | -28.8% | Stock Analytics | |
| NURECA | ₹311.4 Cr | -0.1% | 42.9% | 38% | Stock Analytics | |
LENSKART SOLUTIONS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LENSKART SOLUTIONS | 1.4% |
5.9% |
|
| SENSEX | 2.2% |
0.9% |
-3.7% |
You may also like the below Video Courses